TNGX
NASDAQ
US
Tango Therapeutics, Inc. - Common Stock
$21.63
▲ +$0.41
(+1.93%)
Vol 2.9M
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.2B
ROE
-60.8%
Margin
-151.2%
D/E
0.00
Beta
1.72
52W
$1–$11
Wall Street Consensus
17 analysts · Apr 20267
Strong Buy
8
Buy
2
Hold
0
Sell
0
Strong Sell
88.2%
Buy Rating
Price Chart
Similar Stocks
SYRE
Spyre Therapeutics Inc
$2.5B
LEGN
Legend Biotech Corp
$4.0B
DNLI
Denali Therapeutics Inc
$2.6B
DYN
Dyne Therapeutics Inc
$3.2B
TWST
Twist Bioscience Corp
$1.9B
CPRX
Catalyst Pharmaceuticals Inc
P/E 13.2
$2.9B
ARQT
Arcutis Biotherapeutics Inc
$3.6B
VERA
Vera Therapeutics, Inc
$3.5B
IDYA
IDEAYA Biosciences Inc
$3.0B
Earnings
Beat rate: 75.0%
Next Report
May 11, 2026
EPS Estimate: $-0.32
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.32 | — | — |
| Dec 2025 | $-0.33 | $-0.29 | +$0.04 |
| Sep 2025 | $-0.05 | $0.14 | +$0.19 |
| Jun 2025 | $-0.35 | $-0.35 | +$0.00 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -79.7% | -79.7% | -79.7% | -79.7% | -60.8% | -60.8% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -1221.4% | -599.1% | -599.1% | -599.1% | -151.2% | -151.2% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 4.75 | 4.75 | 4.75 | 4.75 | 8.88 | 8.88 |
Key Ratios
ROA (TTM)
-38.7%
P/S (TTM)
17.94
P/B
1.7
EPS (TTM)
$-0.92
CF/Share
$-1.08
Rev Growth 3Y
+4.3%
52W High
$11.20
52W Low
$1.03
$1.03
52-Week Range
$11.20
How does TNGX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
TNGX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
17.9
▲
40%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
1.7
▼
32%
below
peers
(2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
TNGX profitability vs Biotechnology peers
ROE
-60.8%
▲
10%
above
peers
(-67.3%)
vs Peers
vs Industry
In line
Net margin
-151.2%
▲
47%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-38.7%
▲
17%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
TNGX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
8.9
▲
100%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.7
▲
77%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
TNGX fundamentals radar
TNGX
Peer median
Industry
TNGX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
TNGX vs peers: key metrics
Latest News
No related news yet